---
category: news
title: "The FSHD Society is deploying powerful AI technology to improve clinical trial design for facioscapulohumeral muscular dystrophy"
excerpt: "The patient advocacy nonprofit is collaborating with BullFrogAI as growing numbers of biopharmas take aim at this genetic muscle disease RANDOLPH, Mass., April 21, 2022 /PRNewswire-PRWeb/ -- The FSHD Society announced that it is launching a collaboration involving the FSHD Clinical Trial Research Network (CTRN) and BullFrogAI,"
publishedDateTime: 2022-04-21T12:09:00Z
originalUrl: "https://www.medindia.net/health-press-release/The-FSHD-Society-is-deploying-powerful-AI-technology-to-improve-clinical-trial-design-for-facioscapulohumeral-muscular-dystrophy-579436-1.htm"
webUrl: "https://www.medindia.net/health-press-release/The-FSHD-Society-is-deploying-powerful-AI-technology-to-improve-clinical-trial-design-for-facioscapulohumeral-muscular-dystrophy-579436-1.htm"
type: article

provider:
  name: Medindia
  domain: medindia.net

topics:
  - AI in Healthcare
  - AI

secured: "v6jhNHH7KvKSUlwd8jWpMvEZATC507d+OoDHSDjJvcqrM5z9FuDoATb0OUH6xoxNx6K5P/LtIMqa2n3Jz4ZicFYTbpyQjc30x422vdRajUU8CtUJDXg+NkweThu4Wis6lyQihPvxI1Hd7XBrglAF933/+8++eC0HXbp780GNY/zgye/vIfLuEjzfQFSeUbJCPy7nl0jNeEmCEk8Vw+Rz6+q6r34p7IT/LWVFfbm8o7FFHMRhampySiPSZaoOpplGJ2H67r3A9B8nuLZ7vbtfXcA2W57N2nbxeTKkAtJ70d+LEPv0WwCw9grJqwj2By4s/Iq0AnPLv4PWvomG5E8fWbZJ9Na+gDO4bgvMJG1gXvI=;OUkzfab6L8/yIqgpr5wCMw=="
---

